Scrip
e-Therapeutics: leveraging unique drug discovery to secure partners
07 September 2009
Sita Shah
Please Login to read the full article.
07 September 2009
Sita Shah
sita.shah@informa.com
As big pharma braces itself for the 2012 "winter of discontent", when several key drugs lose patent protection, these patent expiries also represent an opportunity for other firms. e-Therapeutics is one such company, whose science is based on discovering novel uses for existing drugs. It is one...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Mergers and acquisitions repositioning multinationals at the helm in India
- GSK and Merck & Co say Indian deaths unrelated to their HPV vaccines
- Ablynx CEO: fundraising lets us take on more risk and responsibility
- NICE and drug budgets under the microscope as UK election looms
COMMENT
Other Informa Comment
FEATURES
- Cellectis: Partner search is on for meganuclease technology
- Roche's Asian partnering head looks to tap regional innovation
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
